Home/ News / Park News

Foundation of European-Mongolian diagnostic reagents

Recently, European-Mongolian (Tianjin) Medical Diagnosis Technology Co., Ltd. laid the foundation. The company is invested by the German European-Mongolian company, located in Phase III bonded logistics zone of the Development Zone, with a total investment of 80 million yuan, covers an area of 24 mu, the construction area of 22000 meters for Mainly engaged in the development and production of clinical immune diagnostic reagents. It is estimated that 10 million yuan tax revenue will be realized after the formal operation of the project. 

The German European-Mongolian company was founded in 1987, it has many branches in Canada, the United Kingdom, Italy,etc. The company is a leader in the development of the field in sera antibody detecting of autoimmune disease, infectious diseases and allergic disease.

Source:Wuqing

Release Time:2015-07-10 14:11:57